Nlcventures
Head of Product and Strategy | ROB'E
Hamburg, Germany. Posted 6 months ago
The role
The Head of Product & Strategy will drive company strategy, product development, and clinical/regulatory pathways. This person will work with the founders to scale an AI-powered robotic platform for echocardiography.
What you will do
- Shape the overall company strategy, business model, and go-to-market approach
- Conduct market, customer, and competitive analyses
- Develop commercialization strategies for Europe and the US
- Translate clinical needs into clear product requirements
- Drive development toward design freeze and product-market fit
- Ensure execution against milestones, timelines, and budget
- Coordinate clinical validation and usability studies
- Support regulatory strategy toward CE marking and FDA approval
- Build and maintain relationships with clinical partners and KOLs
- Prepare investor materials and support fundraising processes
Required qualifications
- Entrepreneurial, hands-on, and driven
- Thrives in fast-paced, ambiguous environments
- Can bridge clinical, technical, and business domains
- Communicates effectively with investors, clinicians, and engineers
- Passionate about improving patient care
Nice to have
- 5–15+ years of experience in MedTech, HealthTech, or medical robotics
- Experience in product development and commercialization
- Familiarity with medical device development (Class I–III)
- Exposure to clinical studies and regulatory processes (CE/FDA)
- Experience with fundraising or investor interactions
- Background in imaging, robotics, or cardiovascular care
- German is a plus
Benefits
- Build a category-defining MedTech company from an early stage
- Work directly with experienced physician-founders
- Take ownership across strategy, product, and company building
- Gain exposure to leading investors and strategic partners
About the company
ROB’E is an early-stage MedTech venture developing an AI-powered robotic platform for echocardiography. The company was founded by Dr. Jury Schewel and Dr. Dimitry Schewel and is part of the venture portfolio of NLC Health Ventures.